Jeremy G. Mattson

Versiti Blood Center of Wisconsin — United States

Medicine · Health Sciences

5h-index71citations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(8), Hemophilia Treatment and Research(7), Blood Coagulation and Thrombosis Mechanisms(4), Blood groups and transfusion(4), Virus-based gene therapy research(3)

Publications18 total

Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice
Blood Advances·2026Open Access
FVIII-associated LDL circulates longer and participates in blood clot formation
Blood·2025Open Access
HTRS2025.O8A.1 Abstract of Distinction The pivotal role of VWF binding to platelet integrin αIIbβ3 in stabilizing the formation of a platelet plug at sites of vascular injury
Research and Practice in Thrombosis and Haemostasis·2025Open Access
The pivotal role of von Willebrand factor binding to platelet αIIbβ3 in stabilizing the formation of a platelet plug at sites of injury
Haematologica·2025Open Access
Enhanced Efficacy of Platelet-Derived FVIII over Plasma FVIII in the Presence of Anti-Platelet Antagonist
Blood·2024Open Access
HTRS2023.O6B.3 FVIII deficiency leads to lower atherogenic ApoB-lipoprotein and higher fibrinolysis
Research and Practice in Thrombosis and Haemostasis·2023Open Access
Platelet αIIbβ3 Receptor Antagonist Impedes the Hemostatic Efficacy of Platelet-Specific FVIII Gene Therapy in Hemophilia a Mice
Blood·2022
A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD
Blood Advances·2022· 6 citedOpen Access
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity
Blood Advances·2021· 5 citedOpen Access
The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression
Blood Advances·2020· 14 citedOpen Access
A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
Research and Practice in Thrombosis and Haemostasis·2019· 6 citedOpen Access
The Severe Spontaneous Bleeding Phenotype in a Novel Hemophilia a Rat Model with an Inversion Mutation Is Rescued By Platelet-Targeted FVIII Expression
Blood·2018
Platelet-Targeted Hyperfunctional Factor IX (FIX) Gene Therapy for Hemophilia B Mice with Pre-Existing Anti-FIX Immunity
Blood·2018
A Murine Model of Type 2N VWD Was Developed By CRISPR/Cas9 Gene Editing and Recapitulates Human Type 2N VWD
Blood·2018
Humanized Von Willebrand Factor-Glycoprotein Ibα Interaction in Mouse Models of Hemostasis and Thrombosis
Blood·2016· 1 cited
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice
Journal of Thrombosis and Haemostasis·2016· 20 citedOpen Access
Targeting FVIII Expression to Platelets for Hemophilia A Gene Therapy Does Not Bare an Apparent Thrombosis Risk
Blood·2015
Phylogenetic analyses of two mitochondrial metabolic genes sampled in parallel from angiosperms find fundamental interlocus incongruence
American Journal of Botany·2008· 19 cited

Frequent Co-authors

Qizhen Shi(13), Robert R. Montgomery(11), Scot A. Fahs(8), Hartmut Weiler(7), Jocelyn A. Schroeder(7), Hongyin Yu(5), Sandra L. Haberichter(4), Patricia A. Morateck(3), Veronica H. Flood(3), Christina K. Baumgartner(2), Aron M. Geurts(2), Jessica Rapten(2), Paul E. Monahan(2), Ziyu Zhang(2), Hayley Lund(2), Wen Dai(2), Lynn Malec(2), Ze Zheng(2), Qi‐Zhen Shi(2), Pamela A. Christopherson(2)